Atlas
Back to RCM
Strategic Advisor·RCM

Roger Davis

Executive in Residence at Frazier Healthcare Partners; Executive Chairman of the Board, RevSpring at Frazier Healthcare Partners / RevSpring

Dallas, Texas

RD
LinkedIn
Why they matter

Three-time RCM CEO now Frazier's healthcare EIR and RevSpring's executive chairman; he underwrites, buys and operates revenue-cycle assets from both sponsor and operator seats.

Background

J. Roger Davis is a three-time healthcare revenue cycle CEO who now sits on the sponsor side as Executive in Residence at Frazier Healthcare Partners. He ran T-System through its $200 million sale to Fidelity National Financial's FNFV Group in 2017, then led Revint Solutions (later Cloudmed, now part of R1 RCM) as CEO from 2018, then served as President and CEO of Tenet Healthcare's Conifer Health Solutions from December 2020 until his retirement at the end of Q1 2023. Earlier roles include Managing Director at Accenture, Executive Director at Perot Systems/Dell Services, VP at GE Healthcare/IDX, and COO of the faculty practice at UT Health Science Center San Antonio; he holds a BA in Business Management/Accounting from UT San Antonio.

Notable deals

  • 2024
    Named Executive Chairman of the Board of RevSpring when Frazier Healthcare Partners acquired the patient engagement and payments platform from GTCR, alongside NEA and 22C Capital.
  • 2017
    As CEO of T-System, led the company's transformation and its $200 million sale to FNFV Group, the investment arm of Fidelity National Financial.
  • 2019
    As CEO of Revint Solutions, acquired Washington & West, adding Quantum Appeals denials and appeals management technology to the revenue integrity platform.
  • 2020
    Appointed President and CEO of Conifer Health Solutions, Tenet Healthcare's revenue cycle subsidiary, following the cancelled Conifer spin-off; retired end of Q1 2023.

Call-prep brief

Background

  • Career operator in healthcare revenue cycle, not a career investor: T-System (CEO, sold to FNFV for $200M in 2017), Revint Solutions (CEO from 2018, the business that became Cloudmed and was rolled into R1 RCM), Conifer Health Solutions (President & CEO Dec 2020 – Q1 2023, Tenet's RCM subsidiary).
  • Consulting and health-IT roots: Accenture, Perot Systems/Dell Services, GE Healthcare/IDX. Texas-based, UT San Antonio.

Current focus

  • Executive in Residence at Frazier Healthcare Partners, i.e. the firm's operating bench for healthcare services and RCM theses.
  • Executive Chairman of the Board at RevSpring since Frazier's March 2024 buyout from GTCR; CEO Scott MacKenzie runs the company day to day.
  • Co-founder and Chairman at LateralCare (launched May 2024), a generative-AI revenue cycle startup — he is actively betting on AI-native RCM, not just legacy BPO.

What he cares about

  • Patient financial engagement and integrated payments as the consolidation vector; buy-and-build over organic scale.
  • Operational proof, not narrative: he has owned denials, coding and collections P&Ls directly.

Recent moves

  • RevSpring acquired TrustCommerce from Waud Capital in February 2026, extending its payment gateway and processor integrations.

Sensitivities

  • Conifer's cancelled spin-off and Tenet's ongoing ownership; avoid framing his tenure as a turnaround that stalled.
  • He chairs a sponsor-owned asset, so live competitive or exit-timing questions on RevSpring will be off limits.

Questions to ask

  1. Post-TrustCommerce, where does RevSpring stop building and start buying in integrated payments?
  2. Having run both a Tenet captive and a sponsor-backed vendor, where does outsourced RCM genuinely beat in-house today?
  3. What did LateralCare teach you about what GenAI actually automates in the revenue cycle versus what still needs humans?

Outreach draft

Subject
Perspective on revenue cycle diligence
Roger — I work on healthcare services investing at [Firm], and we're underwriting an asset in patient financial engagement and RCM. Your path makes you unusually relevant: T-System through the FNFV sale, Revint through the Washington & West deal, Conifer at Tenet scale, and now RevSpring from the executive chairman seat. I'd value 20 minutes on how you'd underwrite RCM vendor consolidation today — where integrated payments genuinely differentiate versus where they're table stakes, and what provider budgets are actually funding. Happy to share our thesis first so it's a two-way conversation rather than a one-sided diligence call. Any time in the next two weeks works. Best, [Your Name] [Firm]

Linked companies

Sources